Methamphetamine use and illicit opioid use during buprenorphine treatment.

ABSTRACT:

Introduction

Although methamphetamine use is rising in the United States, its impacts on patient outcomes among persons undergoing treatment for opioid use disorder (OUD) remain unclear. This study aims to assess the association between baseline methamphetamine/amphetamine (MA/A) use and subsequent illicit opioid use among patients with OUD initiating buprenorphine in an office-based setting.

Methods

We conducted a secondary analysis of a pilot randomized controlled trial of a behavioral mobile health intervention for buprenorphine adherence conducted over a 12-week study period at two clinic sites. The study defined baseline MA/A use by a positive urine drug test (UDT) and/or self-report of use within the past 30-days. Separate Poisson regression models with robust standard

SUBMITTER: Kratina-Hathaway Z 

PROVIDER: S-EPMC10554569 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature